|
Tissue Acquisition for Molecular Diagnostics Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Tissue Acquisition for Molecular Diagnostics conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Tissue Acquisition for Molecular Diagnostics Clinical research trials and Tissue Acquisition for Molecular Diagnostics health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Tissue Acquisition for Molecular Diagnostics. Tissue Acquisition for Molecular Diagnostics Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Tissue Acquisition for Molecular Diagnostics clinical trial. Participants oftentimes recieve the most expert healthcare available for their Tissue Acquisition for Molecular Diagnostics condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Tissue Acquisition for Molecular Diagnostics  Tissue Acquisition for Molecular Diagnostics
Tissue Acquisition for Molecular Diagnostics
For Condition: Neoplasm
Status: Completed
Sponsor(s): National Cancer Institute (NCI) ,
Synopsis: Acquisition of fresh tumor and normal tissue samples are necessary for the preparation of cDNA libraries, microarray chips, and tissue specific probes, and proteomics development and validation. This protocol will allow acquisition of samples at the time of tissue sampling for surgery, diagnostic tests, or therapeutic phereses. These samples will be forwarded without patient identifiers, pathology reports, or other labels. Tissue pathology will be verified within the Laboratory of Pathology and samples used strictly for CGAP and Proteomic Initiative indications.
Details: Acquisition of fresh tumor and normal tissue samples is necessary for the preparation of cDNA libraries, microarray chips, tissue specific probes, and proteomics development and validation. This protocol will allow acquisition of patient samples at the time of tissue sampling for surgery, diagnostic tests, or therapeutic phereses. These samples will be forwarded without patient identifiers, pathology reports, or other labels. Tissue pathology will be verified within the Laboratory of Pathology and samples used strictly for CGAP and Proteomic Initiative indications.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: All patients willing to sign the informed consent for whom tissue, blood or body fluids will be available are eligible. Histopathologic diagnosis will be confirmed in the Laboratory of Pathology, National Cancer Institute and is not a criteria for inclusion.
Total Enrollment: 50
Location and Contact Information:
National Cancer Institute (NCI)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 970138; 97-C-0138
Study Start Date: June 13, 1997
Record last reviewed: March 28, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001580
Other Neoplasm Studies:
1. Phase I/II Study of Tac-Expressing Malignancies [Other than Adult T-Cell Leukemia (ATL)] with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA
2. Vaccine Therapy and Detection of Immunologic Responses with Tumor Specific Mutated RAS Peptides in Adult Cancer Patients with Solid Tumors
3. A Phase I Trial of Oral Perifosine with Different Loading Schedules in Patients with Refractory Neoplasms
4. Treatment of Patients with Cancer with Genetically Modified Salmonella Typhimurium Bacteria
5. A Pilot Study of Oxaliplatin in Combination with Capecitabine in Adult Cancer Patients
Related Studies:
Other Neoplasm Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Tissue Acquisition for Molecular Diagnostics
|
|
|
|
|
|
|
|
